C

COCP

COCP

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
50%Neutral
Buy/Sell Ratio100% buys
BearishBullish
COCP Live QuoteReal-time
$0.95
+$0.04(+4.40%)1M
Day Range$0.91 – $0.97
Open$0.95
Previous Close$0.97
Volume42.7K
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$18.49M
P/E Ratio (TTM)24.5
Forward P/ENaN
EPS (TTM)$-0.76
Price to Book7.3
Dividend Yield0.65%
Beta (Volatility)1.61
IndustryBIOTECHNOLOGY
52-Week RangeCurrent: $0.95 (15%)
Low: $0.76High: $2.03
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$8.00-94.7% upside

Insider Buys

9

$300K

Insider Sales

0

$0

Total Volume

$300K

18 transactions

Net Activity

+$300K

Net buying

Proprietary Ratings
Calculated from Form 4 transactions
65CONFIDENCE

Sentiment Rating

Moderate Accumulation

CEO Conviction Index

No Recent Signal

Key Drivers

  • •Strong buying bias: purchases represent 100% of total transaction value.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
M
1

Multiple Insiders

P - Purchase Insiders

0 buys9 sells

$593.27B total

F
2

Frost Phillip Md Et Al

Dir, 10%

9 buys0 sells

$300K total

Trading History
COCP insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Aug 5, 2026

3 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell2.02M$10000.00$20.21B

Aug 5, 2026

3 months ago

Frost Phillip Md Et Al

Dir, 10%

Director
Buy10.0K$0.98$10K

Aug 3, 2026

3 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell2.01M$75000.00$150.80B

Aug 3, 2026

3 months ago

Frost Phillip Md Et Al

Dir, 10%

Director
Buy75.0K$0.94$71K

Feb 24, 2026

8 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell1.94M$20000.00$38.71B

Feb 24, 2026

8 months ago

Frost Phillip Md Et Al

Dir, 10%

Director
Buy20.0K$1.00$20K

Feb 6, 2026

9 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell1.92M$50000.00$95.78B

Feb 6, 2026

9 months ago

Frost Phillip Md Et Al

Dir, 10%

Director
Buy50.0K$0.95$47K

Dec 31, 2025

10 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell1.87M$50000.00$93.28B

Dec 31, 2025

10 months ago

Frost Phillip Md Et Al

Dir, 10%

Director
Buy50.0K$0.95$47K

Dec 30, 2025

10 months ago

Frost Phillip Md Et Al

Dir, 10%

Director
Buy20.0K$0.97$19K

Dec 30, 2025

10 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell1.82M$20000.00$36.31B

Dec 24, 2025

11 months ago

Frost Phillip Md Et Al

Dir, 10%

Director
Buy65.0K$0.97$63K

Dec 24, 2025

11 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell1.80M$65000.00$116.72B

Nov 26, 2025

11 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell1.73M$4000.00$6.92B

Nov 26, 2025

11 months ago

Frost Phillip Md Et Al

Dir, 10%

Director
Buy4.0K$0.99$4K

Nov 25, 2025

12 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell1.73M$20000.00$34.53B

Nov 25, 2025

12 months ago

Frost Phillip Md Et Al

Dir, 10%

Director
Buy20.0K$0.94$19K
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
COCP Buy Conviction100%
Industry Rank#0 of 569
Volume Contribution0.0%
Total Industry Activity$16.52B

COCP has an insider buy conviction of 100%, compared to the Unknown sector buy average of 6%.

Insider Trading Summary & Commentary
Automated executive transaction analysis for COCP

Over the last 90 days, corporate insiders at COCP (COCP) engaged in a total of 18 transactions reported via SEC Form 4 filings. Among these, 9 were open-market purchases and 0 were sales. The total volume of insider trading reached $300K.

The net insider activity for COCP shows a net buying bias of $300K. This activity represents a 100% buy ratio, suggesting that insiders are currently strongly bullish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Multiple Insiders (P - Purchase Insiders), who traded 2.01M shares valued at $150.80B on Aug 3, 2026.

Live Market News & Developments
Aggregated real-time headlines for COCP (COCP)
6 updates

Cocrystal Pharma Stock Price Forecast. Should You Buy COCP?

StockInvest.us3d ago

Cocrystal Pharma (Nasdaq:COCP) - Stock Analysis

Simply Wall St3d ago

COCP: Phase 1b Norovirus Challenge Study Results Near Year-End 2026

Yahoo Finance2d ago

COCP - Cocrystal Pharma Inc Stock Price and Quote

Finviz178d ago

Norovirus causes 685 million cases yearly. A 32-adult drug study has finished dosing.

Stock Titan6d ago

COCP Forecast — Price Target — Prediction for 2027

TradingView147d ago

FAQs About COCP Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for COCP.

Based on SEC Form 4 disclosures, the Insider Confidence Score for COCP is currently 65/100, which reflects a moderate accumulation bias. This calculation accounts for a total of 9 purchases and 0 sales by company executives over the last 90 days.

The CEO Conviction Index for COCP is rated as "No Recent Signal". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.